Lifecore Biomedical Receives Sector Weight Rating from KeyBanc Capital Markets

jueves, 4 de septiembre de 2025, 2:07 pm ET1 min de lectura
LFCR--

Lifecore Biomedical has been given a Sector Weight rating by KeyBanc Capital Markets, citing a balanced outlook for its growth prospects. Analyst Paul Knight notes the company's focus on the fill/finish side of the pharmaceutical manufacturing process and its diversified client base as key drivers of its growth.

Lifecore Biomedical Receives Sector Weight Rating from KeyBanc Capital Markets

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios